These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 4558903)

  • 1. Intravenous injection in man of 9 -tetrahydrocannabinol and 11-OH- 9 -tetrahydrocannabinol.
    Perez-Reyes M; Timmons MC; Lipton MA; Davis KH; Wall ME
    Science; 1972 Aug; 177(4049):633-5. PubMed ID: 4558903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of 9-tetrahydrocannabinol for intravenous injection.
    Olsen JL; Makhani M; Davis KH; Wall ME
    J Pharm Pharmacol; 1973 Apr; 25(4):344. PubMed ID: 4146693
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects on humans of 9 -tetrahydrocannabinol administered by smoking.
    Galanter M; Wyatt RJ; Lemberger L; Weingartner H; Vaughan TB; Roth WT
    Science; 1972 May; 176(4037):934-6. PubMed ID: 4555981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison among four vehicles and four routes for administering delta9-tetrahydrocannabinol.
    Sofia RD; Kubena RK; Barry H
    J Pharm Sci; 1974 Jun; 63(6):939-41. PubMed ID: 4851104
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparison of the pharmacological activity in man of intravenously administered delta9-tetrahydrocannabinol, cannabinol, and cannabidiol.
    Perez-Reyes M; Timmons MC; Davis KH; Wall EM
    Experientia; 1973 Nov; 29(11):1368-9. PubMed ID: 4761242
    [No Abstract]   [Full Text] [Related]  

  • 6. Delta-8- and delta-9-tetrahydrocannabinol comparison in man by oral and intravenous administration.
    Hollister LE; Gillespie HK
    Clin Pharmacol Ther; 1973; 14(3):353-7. PubMed ID: 4698563
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term use of marihuana and the development of tolerance or sensitivity to delta9 tetrahydrocannabinol.
    Perez-Reyes M; Timmons MC; Wall ME
    Arch Gen Psychiatry; 1974 Jul; 31(1):89-91. PubMed ID: 4835989
    [No Abstract]   [Full Text] [Related]  

  • 8. An intravenous formulation of 9-tetrahydrocannabinol using a non-ionic surfactant.
    Cradock JC; Davignon JP; Litterst CL; Guarino AM
    J Pharm Pharmacol; 1973 Apr; 25(4):345. PubMed ID: 4146694
    [No Abstract]   [Full Text] [Related]  

  • 9. Vehicle and route of administration as parameters affecting operant behavioral effects of 9 -tetrahydrocannabinol.
    Borgen LA; Davis WM
    J Pharm Sci; 1973 Mar; 62(3):479-80. PubMed ID: 4691712
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute pulmonary physiologic effects of smoked marijuana and oral (Delta)9 -tetrahydrocannabinol in healthy young men.
    Tashkin DP; Shapiro BJ; Frank IM
    N Engl J Med; 1973 Aug; 289(7):336-41. PubMed ID: 4718513
    [No Abstract]   [Full Text] [Related]  

  • 11. 11-hydroxy- 9 -tetrahydrocannabinol: pharmacology, disposition, and metabolism of a major metabolite of marihuana in man.
    Lemberger L; Crabtree RE; Rowe HM
    Science; 1972 Jul; 177(4043):62-4. PubMed ID: 5041775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrocardiographic effects of marihuana.
    Kochar MS; Hosko MJ
    JAMA; 1973 Jul; 225(1):25-7. PubMed ID: 4123475
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparison of the pharmacological activity of delta 9-tetrahydrocannabinol and its monohydroxylated metabolites in man.
    Perez-Reyes M; Timmons MC; Lipton MA; Christensen HD; Davis KH; Wall ME
    Experientia; 1973 Aug; 29(8):1009-10. PubMed ID: 4582081
    [No Abstract]   [Full Text] [Related]  

  • 14. An inhalation aerosol of delta9-tetrahydrocannabinol.
    Olsen JL; Lodge JW; Shapiro BJ; Tashkin DP
    J Pharm Pharmacol; 1976 Jan; 28(1):86. PubMed ID: 6665
    [No Abstract]   [Full Text] [Related]  

  • 15. Cannabidiol interferes with the effects of delta 9 - tetrahydrocannabinol in man.
    Karniol IG; Shirakawa I; Kasinski N; Pfeferman A; Carlini EA
    Eur J Pharmacol; 1974 Sep; 28(1):172-7. PubMed ID: 4609777
    [No Abstract]   [Full Text] [Related]  

  • 16. Interactions in man of delta-9-tetrahydrocannabinol. II. Cannabinol and cannabidiol.
    Hollister LE; Gillespie H
    Clin Pharmacol Ther; 1975 Jul; 18(1):80-3. PubMed ID: 1097148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Letter: Marihuana dosage control through heart rate.
    Schaefer CF; Gunn CG; Dubowski KM
    N Engl J Med; 1975 Jul; 293(2):101. PubMed ID: 1128639
    [No Abstract]   [Full Text] [Related]  

  • 18. Tolerance to marijuana-induced tachycardia in man.
    Gibbins RJ; McDougall J; Miles CG; Marshman JA
    Acta Pharmacol Toxicol (Copenh); 1976 Jul; 39(1):65-76. PubMed ID: 782158
    [No Abstract]   [Full Text] [Related]  

  • 19. Some correlates of marihuana self-administration in man: a study of titration of intake as a function of drug potency.
    Cappell H; Kuchar E; Webster CD
    Psychopharmacologia; 1973; 29(3):177-84. PubMed ID: 4702271
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of four vehicles for intraperitoneal administration of -tetrahydrocannabinol.
    Sofia RD; Kubena RK; Barry H
    J Pharm Pharmacol; 1971 Nov; 23(11):889-91. PubMed ID: 4400204
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.